                         SEQUENCE LISTING

<110>  H. Lee Moffitt Cancer Center and Research Institute, Inc.
       ANP Technologies, Inc.
 
<120>  TLR9-TARGETED THERAPEUTICS

<130>  320301-2040

<150>  US 62/760,362
<151>  2018-11-13

<160>  2     

<170>  PatentIn version 3.5

<210>  1
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  misc_feature
<222>  (1)..(20)
<223>  Phosphorothioate backbone

<400>  1
tccatgacgt tcctgatgct                                                   20


<210>  2
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  misc_feature
<222>  (1)..(20)
<223>  Phosphorothioate backbone

<400>  2
tccatgagct tcctgatgct                                                   20


